11th Annual Sickle Cell and Thalassaemia Conference (ASCAT) in London UK, 11th -13th October 2017

Speakers and Presentations

Click to each title to download presentations by guest speakers.

Dr Alexis Thompson, Hematology Section Head, Ann & Robert H. Lurie Children’s Hospital of Chicago – Sickle Cell Action – ASH Global Agenda

Dr Andrew Dunham, Chief Scientific Officer, Hemanext – Control of Oxidative damage in RBC for transfusion

Prof Anne Greenough, Professor of Neonatal and Clinical Respiratory Physiology, King’s College London – Do patients with sickle cell disease have asthma?

Dr Carsten W. Lederer, Cyprus Institute of Neurology and Genetics (CING) – Genome editing for the therapy of beta-haemoglobinopathies

Dr Caterina Minniti, Professor of Clinical Medicine and Pediatrics, Einstein College of Medicine – Leg Ulcers

Cathy Coppinger, NHS sickle cell and thalassaemia screening programme manager, PHE Screening – Learning from Parents Stories’

Dr Chris Lambert, Service Delivery Manager – Haematology, Haematology Department, King’s College Hospital – Laboratory diagnosis of Haemoglobinopathies

Dr Corina McMahon – Acute Chest syndrome in children: A management protocol

Dr Elizabeth Klings, Associate Professor, Boston University School of Medicine – Pulmonary hypertension, obstructive sleep apnoea and the endothelium in sickle cell disease

Dr Emma Drasar, Consultant Haematologist, Whittington Hospital NHS – Thalassaemia case scenarios

Mr George Constantinou – Iron chelation therapy in thalassaemia – a patient’s journey

Dr Gian Luca Forni, Centro Anemie Congenite, Ospedale Galliera Genoa-Italy – Efficiency and safety of slidenafil in the treatment of severe pulmonary hypertension in patients with haemoglobinopathies

Dr Jacques Elion, Professor of Molecular Genetics, Paris Diderot Medical School, Sorbonne Paris Cite University – Chasing sickle cell disease globally: Capacity Building

Karen Smith Wong – Experienced RN Coordination of Pediatric sickle cell patients in the office and outpatient clinic setting: A comprehensive, Pro-Active Nursing Model

Dr Kathryn Hassell, Director of Colorado Sickle Cell Treatment and Research Centre, University of Colorado – Thromboembolism

Dr Kimberley Wesley, Paediatric Psychologist, Children’s Hospital, Philadelphia – Caregiver Perspectives of Stigma Associated with sickle cell disease in adolescents

Dr Lewis Hsu, Professor of Pediatrics and Director of Pediatric Sickle Cell at the University of Illinois, Chicago – Community Health Worker Support; Health Maintenance

Dr Marina Kleanthous, Professor at The Cyprus School of Molecular Medicine, Head Molecular genetics, Thlassaemia Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus – Prevention of hamoglobinopathies: new methodologies and procedures

Dr Mark Velangi, Consultant Paediatric Haematologist, Birmingham Children’s Hospital – hyperhaemolysis – consensus on diagnosis/management

Dr Marsha Treadwell, Psychologist and Clinical Health services researcher, UCSF Benioff Children’s Hospital Oakland and Co-principal investigator, Pacific sickle cell regional collaborative – Search for a cure for sickle cell disease and thalassemia should be the priority – Yes

Dr Michele Arigliani, University Hospital of Udine, Italy – Respiratory Impairment in children with sickle cell anaemia differences between the UK and Nigeria

Dr Miguel Abboud, Professor and Chairman, Department of Pediatrics and Adolescent Medicine, American University of Beirut – Medical Center, Children’s Cancer Center of Lebanon, Beirut, Lebanon – New Therapies for sickle cell disease

Dr Mona Hamdy, Professor of Pediatrics, Cairo University – Prenatal diagnosis for thalassaemia in Egypt: What changed parents’ attitudes?

Dr Rafaella Colombatti, Pediatric Hematologist Oncologist, Pediatric Hematology, Oncology Unit Azienda Ospedaliera, University of Padova – Coagulation activation and cerebral vasculopathy in SCD

Dr Renu Saxena, Professor and Head of Department of Hematology, AIIMS, New Delhi – Thalassaemia Intermedia in India: genotypic phenotypic correlations

Roanna Maharaj – Iron chelation therapy in thalassaemia – a patient’s journey

Samuel Mbunya – Outreach programs and advocacy of Sickle Cell Disease Care in Kenya

Dr Winfred Wang, Member, St Jude Children’s Research Hospital – Sickle Cell Disease: An overview


Sickle Cell Disease - Pain and Common Chronic Complications

Edited by Baba Psalm Duniya Inusa, ISBN 978-953-51-2767-3, Print ISBN 978-953-51-2766-6, 280 pages,

Publisher: InTech, Chapters published November 10, 2016 under CC BY 3.0 license
DOI: 10.5772/62012
Edited Volume

This book addresses a wide range of clinically relevant topics and issues in sickle cell disease. This is written by experts in their own field offering a robust, engaging discussion about the presentations and mechanisms of actions in the multiple complications associated with sickle cell disease. This first of the series addresses pain, which is considered the hallmark of sickle cell presentation. It looks at the basic mechanism of pain in sickle cell disease. A more detailed review of precision medicine gives a clear well laid out presentation that is incisive and yet gives in-depth detail relevant to both the clinician and the researcher in the basic laboratory. The same pattern is shown in the discussion on respiratory, cardiac and neurological complications. The 14 chapters also include an overview of sickle cell disease especially in the paediatric age.

The content is organized into well-designed broad sections on overview regarding diagnosis including point of care and the role of digital apps in patient management. A key aspect of the book is the opportunity it affords expert physicians to express well-reasoned opinions regarding complex issues in sickle cell disease. The readership would find that it provides a well-described, concise and immediate applicable answers to complex questions. This is highly recommended for scientists and clinicians alike.


10th Annual Sickle Cell and Thalassaemia Conference (ASCAT) in London UK, 5th -7th October 2016

Speakers and Presentations

Click to each title to download presentations by guest speakers.

Alexis Thompson - American Society for Hematology

Ali TaherEvidence-Based Approach to Managing Non-Transfusion-Dependent Thalassemias (NTDT)

Barnaby Clark - Haemoglobinopathy diagnosis

Caterina Minniti - Chronic Organ Damage in Sickle Cell Anaemia

Claire Sharpe - Renal complications

Dagan Wells - New technique of karyomapping for PGD

David Roberts - Thousands of genetic variants

Deepika Darbari - Deconstructing Pain in Sickle Cell Disease

Elizabeth Klings - Pulmonary HTN

Emma Drasar - Thalassaemia case scenarios

Greg Kato - Augmenting Nitric Oxide Signaling in SCD

Jerlym Porter - Transition skills training

Jo Howard - Haemoglobin modifiers

Jo Howard - NICE guidance on spectra optiav2

Kalpna Gupta - Promising strategies to treat pain in sickle cell disease

Ken Ataga - Endothelial Dysfunction and Albuminuria in Sickle Cell Disease

Léon Tshilolo - National Development of SCD Programmes in Congo DR

Marsha Treadwell - Patient Reported Outcomes for the Hemoglobinopathies

Matt Heeney - Anti-adhesion agents

Service to Humanity Foundation

Simon Robertson - Virtual reality as a complementary therapy

Stephan Lobitz - Emerging haemoglobinopathies services



Standards for the Clinical Care of Children and Adults with Thalassaemia in the UK

The 3rd edition (May 2016) of the Standards for the Clinical Care of Children and Adults with Thalassaemia in the UK is available now.


Excellence in Oncology and Haematology Nursing


Published on 17 Dec 2015

Brought to you in association with Novartis Oncology.

The video is centered around the work of Luhanga Musumadi, an advanced nurse practitioner for sickle cell at Guy’s and St Thomas’ hospital (which includes the Evelina Children’s Hospital). He explains how he has set up and managed the transition service for young people with sickle cell and thalassaemia, supporting and preparing them for their move from the children’s environment into the adult services.